About Bioscience
Bioscience is a company based in Allentown (United States) founded in 1984. Bioscience has raised $17 million across 2 funding rounds from investors including Perceptive Advisors and Xontogeny. Bioscience offers products and services including MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit. Bioscience operates in a competitive market with competitors including Pentair, ACCIONA, GSK, Avidity Biosciences and Sutro Biopharma, among others.
- Headquarter Allentown, United States
-
Sectors
HealthcareEnvironment
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Monera Technologies Corporation
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$17 M (USD)
in 2 rounds
-
Latest Funding Round
$17 M (USD), Series A
Dec 10, 2019
-
Investors
Perceptive Advisors
& 1 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bioscience
Bioscience offers a comprehensive portfolio of products and services, including MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit.
Enhances biological activity for wastewater treatment in various applications
Fills and seals ampules for microbial product preparation
Measures chemical oxygen demand in wastewater samples
Funding Insights of Bioscience
Bioscience has successfully raised a total of $17M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $17 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $17.0M
- First Round First Round
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2019 | Amount | Series A - Bioscience | Valuation | Perceptive Advisors |
|
| Jun, 2017 | Amount | Unspecified - Bioscience | Valuation | Xontogeny |
|
Investors in Bioscience
Bioscience has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include Perceptive Advisors and Xontogeny.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Life science startups are accelerated through focused programs by Xontogeny.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Bioscience
Financial Statements - Bioscience
Bioscience Comparisons
Competitors of Bioscience
Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pentair, ACCIONA, GSK, Avidity Biosciences and Sutro Biopharma, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Water and waste treatment services are provided worldwide.
|
|
| domain | founded_year | HQ Location |
Sustainable infrastructure solutions in renewable energy are developed and managed.
|
|
| domain | founded_year | HQ Location |
Developer of pharmaceuticals and vaccines for various therapeutic areas
|
|
| domain | founded_year | HQ Location |
Antibody-siRNA complexes are developed for cancer treatment.
|
|
| domain | founded_year | HQ Location |
Antibody-based therapeutics for cancer therapy are developed via cell-free synthesis.
|
|
| domain | founded_year | HQ Location |
Yeast cells are genetically engineered to produce medicinal products.
|
Latest news on Bioscience
Frequently Asked Questions about Bioscience
Bioscience was founded in 1984 and raised its 1st funding round 33 years after it was founded.
Bioscience is headquartered in Allentown, United States. It is registered at Allentown, Pennsylvania, United States.
Bioscience is a funded company, having raised a total of $17M across 2 funding rounds to date.
Bioscience, Inc. was founded in 1984 and is headquartered in Allentown, United States. Operations are centered in industrial microbiology, where microbial products and solutions are developed for biological wastewater treatment. Analytical products and test kits are manufactured for wastewater analysis. The MICROCAT brand is applied in bioaugmentation, process improvement, and stabilization across municipal, industrial, commercial, aquacultural, agricultural, and residential sectors.
Bioscience's top competitors include ACCIONA, Sutro Biopharma and Pentair.
Bioscience offers MICROCAT Products, Ampulmatic-10, and accu-TEST COD Testing Kit.
Bioscience has 2 investors. Key investors include Perceptive Advisors, and Xontogeny.